Leila Amini

7PUBLICATIONS
82CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Infant and child healthCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 09, 2026
The ProTreg21 Protocol: Phase I/IIa Regulatory T cell Therapy Clinical Trial in Deceased-Donor Kidney Transplantation.

|Oct 13, 2025
HLA matching or CRISPR editing of HLA class I/II enables engraftment and effective function of allogeneic human regulatory T cell therapy in a humanized mouse transplantation model.

Oliver McCallion, Weijie Du, Viktor Glaser

|Mar 13, 2025
TGFβ links EBV to multisystem inflammatory syndrome in children.

Carl Christoph Goetzke, Mona Massoud, Stefan Frischbutter

|Sep 04, 2024
Effector memory-type regulatory T cells display phenotypic and functional instability.

Désirée Jacqueline Wendering, Leila Amini, Stephan Schlickeiser

|Mar 23, 2022
Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion.

Leila Amini, Sara K Silbert, Shannon L Maude

|Jan 14, 2021
The intratumoral CXCR3 chemokine system is predictive of chemotherapy response in human bladder cancer.

Tino Vollmer, Stephan Schlickeiser, Leila Amini

Pageof 2

Frequent Collaborators

4 joint publications

Hans-Dieter Volk

4 joint publications

Michael Schmueck-Henneresse

4 joint publications

Petra Reinke

3 joint publications

Dimitrios Laurin Wagner